INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Cutaneous Leishmaniasis: Updates in Diagnosis and Management.

The Rickettsioses: A Practical Update.

Chikungunya: Epidemiology, Pathogenesis, Clinical Features, Management, and Prevention.

Respiratory Virus Infections of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient

Human Monkeypox: Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention.

HIV and Aging: Reconsidering the Approach to Management of Comorbidities.

Human African Trypanosomiasis: Progress and Stagnation.

Venomous Bites, Stings, and Poisoning: An Update.

Novel Avian Influenza A Virus Infections of Humans.

Ebola Virus Disease: Epidemiology, Clinical Features, Management, and Prevention.

Viral Hepatitis: Etiology, Epidemiology, Transmission, Diagnostics, Treatment, and Prevention.

Antibiotic-Resistant Enteric Infections.

Antibiotic-Resistant Community-Acquired Bacterial Pneumonia.

Multidrug and Extensively Drug-resistant Tuberculosis: Epidemiology, Clinical Features, Management and Treatment.

Lassa Fever: Epidemiology, Clinical Features, Diagnosis, Management and Prevention.

Chemotherapy and Beyond: Infections in the Era of Old and New Treatments for Hematologic Malignancies.

Viral Hemorrhagic Fevers Other than Ebola and Lassa.

Key Principles of Antiretroviral Pharmacology.

Antimicrobial Resistance in the Tropics.

Sound Around the World: Ultrasound for Tropical Diseases.

Cytomegalovirus Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patient.

Management of Virologic Failure and HIV Drug Resistance

On the Road to a HIV Cure: Moving Beyond Berlin and London.

Invasive Pneumococcal and Meningococcal Disease.

Opportunistic Infections in Transplant Patients.

Herpes Virus Infections Other than Cytomegalovirus in the Recipients of Hematopoietic Stem Cell Transplantation.

Evidence-Based Clinical Management of Ebola Virus Disease and Epidemic Viral Hemorrhagic Fevers.

Migration Medicine.

Bacterial Infections in the Stem Cell Transplant Recipient and Hematologic Malignancy Patient.

Neurocysticerosis: An Individualized Approach.

Infections with DNA Viruses, Adenovirus, Polyomaviruses, and Parvovirus B19 in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies.

Collaborative Antimicrobial Stewardship: Working with Hospital and Health System Administration.

Antimicrobial Prophylaxis and Preemptive Approaches for the Prevention of Infections in the Stem Cell Transplant Recipient, with Analogies to the Hematologic Malignancy Patient.

HIV and Substance Use Disorder: Role of the HIV Physician.

Work-up for Fever During Neutropenia for Both the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient.

Antiretroviral Medications for the Prevention of Human Immunodeficiency Virus Infection: A Clinical Approach to Preexposure Prophylaxis, Postexposure Prophylaxis, and Treatment as Prevention.

Initial Antiretroviral Therapy in an Integrase Inhibitor Era: Can We Do Better?

Human Immunodeficiency Virus Diagnostics: Current Recommendations and Opportunities for Improvement.

How Big Data Science Can Improve Linkage and Retention in Care.

Why Everyone (Almost) with Human Immunodeficiency Virus Needs to Be on Treatment: A Review of the Critical Data.

Bugs and Drugs: Collaboration Between Infection Prevention and Antibiotic Stewardship.

Collaborative Antimicrobial Stewardship: Working with Information Technology.

Human Immunodeficiency Virus Initial Assessment and Routine Follow-up: What Tests to Order and Why.

Collaborative Antimicrobial Stewardship in the Health Department.

Switching Antiretroviral Therapy in the Setting of Virologic Suppression: A Why and How-To Guide.